Actively Recruiting
Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression
Led by Centre Hospitalier Universitaire de la Guadeloupe · Updated on 2025-11-17
3000
Participants Needed
2
Research Sites
N/A
Total Duration
On this page
Sponsors
C
Centre Hospitalier Universitaire de la Guadeloupe
Lead Sponsor
I
Institut National de la Santé Et de la Recherche Médicale, France
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are studying the progression and development of prostate cancer, which varies greatly between individuals based on genetic, clinical, and environmental factors as well as ethno-geographic origins. The goal is to identify factors that influence how the disease evolves, including risks of complications and treatment responses. This knowledge aims to support better treatment choices and improve prevention and screening, especially in high-risk populations. The study involves two groups of newly diagnosed prostate cancer patients from Guadeloupe and Rennes, representing different ethno-geographic backgrounds. Patients will be included before starting treatment and followed over time. Data collection includes questionnaires about lifestyle, medical and occupational history, and socio-demographic information. Biological samples like saliva, urine, and blood will be taken for genetic and environmental analysis. Patients will receive standard care, with additional sample collections for detailed biological studies. Participants will have regular follow-up visits at diagnosis and at 1, 2, 5, and 10 years after inclusion and treatment start. During these visits, clinical data, anthropometric measurements, and blood pressure will be recorded. Questionnaires will assess quality of life and other health factors. The study will measure associations between various determinants and health events related to prostate cancer progression and other health issues over time. This long-term monitoring aims to improve understanding of the disease course and outcomes.
CONDITIONS
Brief Title
Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients with a new diagnosis of prostate cancer
- Patients consulting at the University Hospital of Guadeloupe or the University Hospital of Rennes
- Residents of Guadeloupe, Martinique, Saint-Martin, or Brittany
- Affiliated with or beneficiaries of social security
- Signed informed consent
You will not qualify if you...
- Physical or mental health conditions preventing participation as judged by the investigator
- Adults under legal protection such as guardianship, curatorship, or safeguard of justice
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 10 years
Participants are followed over time with structured questionnaires, clinical data collection, and biological sample collection to observe disease progression and other health events.
Visits at the start of the study, and at 1, 2, 5, and 10 years after inclusion and after starting treatment
Trial Site Locations
Total: 2 locations
1
CHU of Rennes
Rennes, Ille-et-Vilaine, France, 35000
Not Yet Recruiting
2
CHU of Guadeloupe
Pointe-à-Pitre, Guadeloupe, Guadeloupe, 97159
Actively Recruiting
Research Team
V
Valérie HAMONY-SOTER
E
Eunice NUBRET
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here